The University of Chicago Header Logo

Connection

Glenn C. Randall to Humans

Back to Details
This is a "connection" page, showing publications Glenn C. Randall has written about Humans.
Glenn C. Randall
Connection Strength
0.581
Humans
  1. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids. PLoS Pathog. 2023 Dec; 19(12):e1011887.
    View in: PubMed
    Score: 0.032
  2. CAPRIN1 Is Required for Control of Viral Replication Complexes by Interferon Gamma. mBio. 2023 06 27; 14(3):e0017223.
    View in: PubMed
    Score: 0.030
  3. Three-Dimensional Cell Culture Systems for Studying Hepatitis C Virus. Viruses. 2021 01 30; 13(2).
    View in: PubMed
    Score: 0.026
  4. Live Cell Imaging of Hepatitis C Virus Trafficking in Hepatocytes. Methods Mol Biol. 2019; 1911:263-274.
    View in: PubMed
    Score: 0.022
  5. Lipid Droplet Metabolism during Dengue Virus Infection. Trends Microbiol. 2018 08; 26(8):640-642.
    View in: PubMed
    Score: 0.022
  6. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process. Cell Host Microbe. 2018 03 14; 23(3):382-394.e5.
    View in: PubMed
    Score: 0.021
  7. Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy. J Virol. 2017 06 01; 91(11).
    View in: PubMed
    Score: 0.020
  8. Flavivirus modulation of cellular metabolism. Curr Opin Virol. 2016 08; 19:7-10.
    View in: PubMed
    Score: 0.019
  9. Spatiotemporal analysis of hepatitis C virus infection. PLoS Pathog. 2015 Mar; 11(3):e1004758.
    View in: PubMed
    Score: 0.017
  10. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides. Virology. 2015 Feb; 476:168-179.
    View in: PubMed
    Score: 0.017
  11. Hepatitis C virus replication compartment formation: mechanism and drug target. Gastroenterology. 2014 May; 146(5):1164-7.
    View in: PubMed
    Score: 0.016
  12. Lipids in innate antiviral defense. Cell Host Microbe. 2013 Oct 16; 14(4):379-85.
    View in: PubMed
    Score: 0.016
  13. EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication. J Virol. 2013 Jun; 87(12):6625-34.
    View in: PubMed
    Score: 0.015
  14. Hepatitis C virus-host interactions, replication, and viral assembly. Curr Opin Virol. 2012 Dec; 2(6):725-32.
    View in: PubMed
    Score: 0.015
  15. Lipids at the interface of virus-host interactions. Curr Opin Microbiol. 2012 Aug; 15(4):512-8.
    View in: PubMed
    Score: 0.014
  16. Molecular determinants and dynamics of hepatitis C virus secretion. PLoS Pathog. 2012 Jan; 8(1):e1002466.
    View in: PubMed
    Score: 0.014
  17. Manipulation or capitulation: virus interactions with autophagy. Microbes Infect. 2012 Feb; 14(2):126-39.
    View in: PubMed
    Score: 0.014
  18. Dengue virus and autophagy. Viruses. 2011 08; 3(8):1332-41.
    View in: PubMed
    Score: 0.013
  19. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J Virol. 2011 Sep; 85(17):8870-83.
    View in: PubMed
    Score: 0.013
  20. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe. 2010 Nov 18; 8(5):422-32.
    View in: PubMed
    Score: 0.013
  21. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A. 2010 Oct 05; 107(40):17345-50.
    View in: PubMed
    Score: 0.013
  22. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog. 2009 Dec; 5(12):e1000702.
    View in: PubMed
    Score: 0.012
  23. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci U S A. 2009 May 05; 106(18):7577-82.
    View in: PubMed
    Score: 0.011
  24. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A. 2007 Jul 31; 104(31):12884-9.
    View in: PubMed
    Score: 0.010
  25. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology. 2006 Nov; 131(5):1584-91.
    View in: PubMed
    Score: 0.010
  26. Interfering with hepatitis C virus RNA replication. Virus Res. 2004 Jun 01; 102(1):19-25.
    View in: PubMed
    Score: 0.008
  27. Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant. Cells. 2024 Jan 23; 13(3).
    View in: PubMed
    Score: 0.008
  28. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci U S A. 2003 Jan 07; 100(1):235-40.
    View in: PubMed
    Score: 0.007
  29. Transcriptional Inhibition of MicroRNA miR-122 by Small Molecules Reduces Hepatitis C Virus Replication in Liver Cells. J Med Chem. 2022 12 22; 65(24):16338-16352.
    View in: PubMed
    Score: 0.007
  30. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat Biotechnol. 2023 01; 41(1):128-139.
    View in: PubMed
    Score: 0.007
  31. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1a/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells. mBio. 2022 10 26; 13(5):e0241522.
    View in: PubMed
    Score: 0.007
  32. The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection. J Biol Chem. 2022 06; 298(6):101956.
    View in: PubMed
    Score: 0.007
  33. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model. Nat Commun. 2022 04 19; 13(1):2028.
    View in: PubMed
    Score: 0.007
  34. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
    View in: PubMed
    Score: 0.007
  35. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022 01 20; 13(1):405.
    View in: PubMed
    Score: 0.007
  36. A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2. Adv Sci (Weinh). 2022 01; 9(2):e2103240.
    View in: PubMed
    Score: 0.007
  37. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant. Biomaterials. 2021 11; 278:121159.
    View in: PubMed
    Score: 0.007
  38. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science. 2021 08 20; 373(6557):931-936.
    View in: PubMed
    Score: 0.007
  39. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Commun Biol. 2021 02 09; 4(1):193.
    View in: PubMed
    Score: 0.006
  40. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun. 2021 02 02; 12(1):743.
    View in: PubMed
    Score: 0.006
  41. RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus. Proc Natl Acad Sci U S A. 2018 08 07; 115(32):8197-8202.
    View in: PubMed
    Score: 0.005
  42. Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release. mBio. 2018 03 13; 9(2).
    View in: PubMed
    Score: 0.005
  43. Transcription of the derepressed open reading frame P of herpes simplex virus 1 precludes the expression of the antisense gamma(1)34.5 gene and may account for the attenuation of the mutant virus. J Virol. 1997 Oct; 71(10):7750-7.
    View in: PubMed
    Score: 0.005
  44. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest. 2017 Apr 03; 127(4):1338-1352.
    View in: PubMed
    Score: 0.005
  45. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology. 2016 Jan; 63(1):49-62.
    View in: PubMed
    Score: 0.004
  46. Identification and comparative analysis of hepatitis C virus-host cell protein interactions. Mol Biosyst. 2013 Dec; 9(12):3199-209.
    View in: PubMed
    Score: 0.004
  47. Functions of autophagy in normal and diseased liver. Autophagy. 2013 Aug; 9(8):1131-58.
    View in: PubMed
    Score: 0.004
  48. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.004
  49. A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 2012 Jan; 142(1):e1-5.
    View in: PubMed
    Score: 0.003
  50. A physical interaction network of dengue virus and human proteins. Mol Cell Proteomics. 2011 Dec; 10(12):M111.012187.
    View in: PubMed
    Score: 0.003
  51. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet. 2007 Oct; 81(4):829-34.
    View in: PubMed
    Score: 0.003
  52. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol. 2004 Feb; 78(3):1448-55.
    View in: PubMed
    Score: 0.002
  53. Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene. J Virol. 1996 Mar; 70(3):1810-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.